Global Aesthetic Injections 麻豆原创 Research Report 2024

Publication ID:

PB505255253

Publication Date:

May 8, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Facial aesthetic treatment with injectable neuromodulators and hyaluronic acid fillers is well established, with favourable safety profiles and consistent outcomes.
The global Aesthetic Injections market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Aesthetic Injections, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aesthetic Injections.
Report Scope
The Aesthetic Injections market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Aesthetic Injections market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Aesthetic Injections companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Galderma
AbbVie (Allergan)
HUGEL
LG Chem
Huons (Humedix)
Bloomage Biotech
Aimei Ke Technology Development
Haohai Biological Technology
Scivision Biotech
Segment by Type
Hyaluronic Acid
Botulinum Toxin
Other
Segment by Application
Hospitals
Aesthetic Clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Aesthetic Injections companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Aesthetic Injections 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hyaluronic Acid
1.2.3 Botulinum Toxin
1.2.4 Other
1.3 麻豆原创 by Application
1.3.1 Global Aesthetic Injections 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Aesthetic Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Aesthetic Injections 麻豆原创 Perspective (2019-2030)
2.2 Aesthetic Injections Growth Trends by Region
2.2.1 Global Aesthetic Injections 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Aesthetic Injections Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Aesthetic Injections Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Aesthetic Injections 麻豆原创 Dynamics
2.3.1 Aesthetic Injections Industry Trends
2.3.2 Aesthetic Injections 麻豆原创 Drivers
2.3.3 Aesthetic Injections 麻豆原创 Challenges
2.3.4 Aesthetic Injections 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Aesthetic Injections Players by Revenue
3.1.1 Global Top Aesthetic Injections Players by Revenue (2019-2024)
3.1.2 Global Aesthetic Injections Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Aesthetic Injections 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Aesthetic Injections Revenue
3.4 Global Aesthetic Injections 麻豆原创 Concentration Ratio
3.4.1 Global Aesthetic Injections 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Aesthetic Injections Revenue in 2023
3.5 Aesthetic Injections Key Players Head office and Area Served
3.6 Key Players Aesthetic Injections Product Solution and Service
3.7 Date of Enter into Aesthetic Injections 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Aesthetic Injections Breakdown Data by Type
4.1 Global Aesthetic Injections Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Aesthetic Injections Forecasted 麻豆原创 Size by Type (2025-2030)
5 Aesthetic Injections Breakdown Data by Application
5.1 Global Aesthetic Injections Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Aesthetic Injections Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Aesthetic Injections 麻豆原创 Size (2019-2030)
6.2 North America Aesthetic Injections 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Aesthetic Injections 麻豆原创 Size by Country (2019-2024)
6.4 North America Aesthetic Injections 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Aesthetic Injections 麻豆原创 Size (2019-2030)
7.2 Europe Aesthetic Injections 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Aesthetic Injections 麻豆原创 Size by Country (2019-2024)
7.4 Europe Aesthetic Injections 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Aesthetic Injections 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Aesthetic Injections 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Aesthetic Injections 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Aesthetic Injections 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Aesthetic Injections 麻豆原创 Size (2019-2030)
9.2 Latin America Aesthetic Injections 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Aesthetic Injections 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Aesthetic Injections 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Aesthetic Injections 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Aesthetic Injections 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Aesthetic Injections 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Aesthetic Injections 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Galderma
11.1.1 Galderma Company Detail
11.1.2 Galderma Business Overview
11.1.3 Galderma Aesthetic Injections Introduction
11.1.4 Galderma Revenue in Aesthetic Injections Business (2019-2024)
11.1.5 Galderma Recent Development
11.2 AbbVie (Allergan)
11.2.1 AbbVie (Allergan) Company Detail
11.2.2 AbbVie (Allergan) Business Overview
11.2.3 AbbVie (Allergan) Aesthetic Injections Introduction
11.2.4 AbbVie (Allergan) Revenue in Aesthetic Injections Business (2019-2024)
11.2.5 AbbVie (Allergan) Recent Development
11.3 HUGEL
11.3.1 HUGEL Company Detail
11.3.2 HUGEL Business Overview
11.3.3 HUGEL Aesthetic Injections Introduction
11.3.4 HUGEL Revenue in Aesthetic Injections Business (2019-2024)
11.3.5 HUGEL Recent Development
11.4 LG Chem
11.4.1 LG Chem Company Detail
11.4.2 LG Chem Business Overview
11.4.3 LG Chem Aesthetic Injections Introduction
11.4.4 LG Chem Revenue in Aesthetic Injections Business (2019-2024)
11.4.5 LG Chem Recent Development
11.5 Huons (Humedix)
11.5.1 Huons (Humedix) Company Detail
11.5.2 Huons (Humedix) Business Overview
11.5.3 Huons (Humedix) Aesthetic Injections Introduction
11.5.4 Huons (Humedix) Revenue in Aesthetic Injections Business (2019-2024)
11.5.5 Huons (Humedix) Recent Development
11.6 Bloomage Biotech
11.6.1 Bloomage Biotech Company Detail
11.6.2 Bloomage Biotech Business Overview
11.6.3 Bloomage Biotech Aesthetic Injections Introduction
11.6.4 Bloomage Biotech Revenue in Aesthetic Injections Business (2019-2024)
11.6.5 Bloomage Biotech Recent Development
11.7 Aimei Ke Technology Development
11.7.1 Aimei Ke Technology Development Company Detail
11.7.2 Aimei Ke Technology Development Business Overview
11.7.3 Aimei Ke Technology Development Aesthetic Injections Introduction
11.7.4 Aimei Ke Technology Development Revenue in Aesthetic Injections Business (2019-2024)
11.7.5 Aimei Ke Technology Development Recent Development
11.8 Haohai Biological Technology
11.8.1 Haohai Biological Technology Company Detail
11.8.2 Haohai Biological Technology Business Overview
11.8.3 Haohai Biological Technology Aesthetic Injections Introduction
11.8.4 Haohai Biological Technology Revenue in Aesthetic Injections Business (2019-2024)
11.8.5 Haohai Biological Technology Recent Development
11.9 Scivision Biotech
11.9.1 Scivision Biotech Company Detail
11.9.2 Scivision Biotech Business Overview
11.9.3 Scivision Biotech Aesthetic Injections Introduction
11.9.4 Scivision Biotech Revenue in Aesthetic Injections Business (2019-2024)
11.9.5 Scivision Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Galderma
AbbVie (Allergan)
HUGEL
LG Chem
Huons (Humedix)
Bloomage Biotech
Aimei Ke Technology Development
Haohai Biological Technology
Scivision Biotech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.